Cargando…

Investigating the Pathogenic Interplay of Alpha-Synuclein, Tau, and Amyloid Beta in Lewy Body Dementia: Insights from Viral-Mediated Overexpression in Transgenic Mouse Models

Lewy body dementia (LBD) is an often misdiagnosed and mistreated neurodegenerative disorder clinically characterized by the emergence of neuropsychiatric symptoms followed by motor impairment. LBD falls within an undefined range between Alzheimer’s disease (AD) and Parkinson’s disease (PD) due to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Melina J., Boschen, Suelen L., Kurti, Aishe, Castanedes Casey, Monica, Phillips, Virginia R., Fryer, John D., Dickson, Dennis, Jansen-West, Karen R., Petrucelli, Leonard, Delenclos, Marion, McLean, Pamela J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604054/ https://www.ncbi.nlm.nih.gov/pubmed/37893236 http://dx.doi.org/10.3390/biomedicines11102863

Ejemplares similares

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
por: Delenclos, Marion, et al.
Publicado: (2017)

Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model
por: Cook, Casey, et al.
Publicado: (2015)

Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant
por: Carlomagno, Yari, et al.
Publicado: (2019)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
por: Wojtas, Aleksandra M., et al.
Publicado: (2020)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
por: Fagen, Sara J., et al.
Publicado: (2023)

Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy
por: Chew, Jeannie, et al.
Publicado: (2019)

Tau exhibits unique seeding properties in globular glial tauopathy
por: Chung, Dah-eun Chloe, et al.
Publicado: (2019)

Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model
por: Jansen-West, Karen, et al.
Publicado: (2022)

369 Differentiating Dementia with Lewy Bodies and Alzheimer’s Disease Using Extracellular Vesicles
por: Bregendahl, Maria, et al.
Publicado: (2023)

An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
por: Carlomagno, Yari, et al.
Publicado: (2017)

Astrocyte-derived clusterin suppresses amyloid formation in vivo
por: Wojtas, Aleksandra M., et al.
Publicado: (2020)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring
por: Kang, Silvia S, et al.
Publicado: (2014)

Interplay between tau and α‐synuclein liquid–liquid phase separation
por: Siegert, Anna, et al.
Publicado: (2021)

Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein
por: Delenclos, Marion, et al.
Publicado: (2017)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
por: Miller, Rebecca L., et al.
Publicado: (2022)

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
por: Iba, Michiyo, et al.
Publicado: (2020)

Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity
por: Nicholson, Alexandra M., et al.
Publicado: (2018)

A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo
por: Delenclos, Marion, et al.
Publicado: (2016)

The AD tau core spontaneously self-assembles and recruits full-length tau to filaments
por: Carlomagno, Yari, et al.
Publicado: (2021)

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
por: Masliah, Eliezer, et al.
Publicado: (2011)

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
por: Park, Jae-Hyeon, et al.
Publicado: (2020)

APOE ε2 is associated with increased tau pathology in primary tauopathy
por: Zhao, Na, et al.
Publicado: (2018)

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
por: Jin, Yunjung, et al.
Publicado: (2022)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

The Mechanisms of the Roles of α-Synuclein, Amyloid-β, and Tau Protein in the Lewy Body Diseases: Pathogenesis, Early Detection, and Therapeutics
por: Noguchi-Shinohara, Moeko, et al.
Publicado: (2023)

Human Neural Progenitor Transplantation Rescues Behavior and Reduces α‐Synuclein in a Transgenic Model of Dementia with Lewy Bodies
por: Goldberg, Natalie R.S., et al.
Publicado: (2017)

Early manifestation of depressive‐like behavior in transgenic mice that express dementia with Lewy body‐linked mutant β‐synuclein
por: Fujita, Masayo, et al.
Publicado: (2018)

Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
por: Hou, Xu, et al.
Publicado: (2023)

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
por: Cook, Casey, et al.
Publicado: (2014)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
por: Sekiya, Hiroaki, et al.
Publicado: (2022)

Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments
por: Adams, Stephanie J., et al.
Publicado: (2010)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
por: Price, Diana L., et al.
Publicado: (2016)

Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein
por: Fujita, Masayo, et al.
Publicado: (2020)

Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models
por: Iba, Michiyo, et al.
Publicado: (2020)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates
por: Jiang, Peizhou, et al.
Publicado: (2017)

Formation of α-synuclein Lewy neurite–like aggregates in axons impedes the transport of distinct endosomes
por: Volpicelli-Daley, Laura A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0a4ea23guot58to81p976f49rl